title: Reversal of severe vasoplegia with single-dose methylene blue after heart transplantation.
authors.affiliation: Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany. kofidis@thg.mh-hannover.de
authors.forename: T
authors.initials: T
authors.lastname: Kofidis
authors.forename: M
authors.initials: M
authors.lastname: Strüber
authors.forename: M
authors.initials: M
authors.lastname: Wilhelmi
authors.forename: M
authors.initials: M
authors.lastname: Anssar
authors.forename: A
authors.initials: A
authors.lastname: Simon
authors.forename: W
authors.initials: W
authors.lastname: Harringer
authors.forename: A
authors.initials: A
authors.lastname: Haverich
mesh_terms: D004791:Enzyme Inhibitors / Q000008:administration & dosage*; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008751:Methylene Blue / Q000008:administration & dosage*; D008875:Middle Aged; D012074:Remission Induction; D014652:Vascular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D014655:Vascular Resistance
chemical_list: D004791:Enzyme Inhibitors; D008751:Methylene Blue